Tandem Control-IQ—Now Authorized For Children
Tandem Diabetes announced FDA clearance of an expanded pediatric indication for the Tandem t:slim X2™ insulin pump with Control-IQ™ technology in children ages six and older.
At ADA, Breakthrough T1D-Funded Research Takes Center Stage (featuring a “Happy Hour” with Dr. Aaron Kowalski)
At the American Diabetes Association’s Scientific Sessions, which was held virtually from June 12-16, scientists presented on some of the most important topics, from artificial pancreas trials to immune therapy trials to prevention trials, all with the same goal: ending type 1 diabetes (T1D) and improving lives until that day comes. Breakthrough T1D played the […]
The Importance of Dexcom CLARITY: From Telemedicine to Ultra Marathons
Elite T1D Athlete Eric Tozer and Dexcom Certified Diabetes Educator (CDE) Cher Pastore discuss Dexcom CLARITY technology.
Severe hypoglycemia: Be prepared, not afraid
Fear of Hypoglycemia is a real thing. Learn how you and your loved ones with T1D can overcome it.
ADA’s Scientific Sessions: Day 4
The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics, from beta cell replacement to regeneration and glucose and complications trials, all with the result to change things for the type 1 diabetes (T1D) community. Here are Drs. Emily Sims, Jay Skyler, Marian Rewers and […]
FreeStyle Libre 2 Authorized for Use in the U.S.
On June 15, 2020, Abbott announced that the FDA has authorized the FreeStyle Libre 2 System. The Libre 2 gained its CE Mark clearance in Europe late 2018 and is now authorized for adults and children 4 and up in the United States. The FreeStyle Libre 2 is a 14 day continuous glucose monitor (CGM) […]
University of Michigan Establishes Elizabeth Weiser Caswell Diabetes Institute
Named for Breakthrough T1D Research Committee member Elizabeth Caswell, Institute will support diabetes research and development of life-changing diabetes therapies.
ADA’s Scientific Sessions: Day 3
The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics, from beta cell replacement to regeneration and glucose and complications trials, all with the result to change things for the type 1 diabetes (T1D) community. Here is Dr. Chantal Mathieu to share her key takeaways […]
Updates from the Teplizumab Trial: You’re Not Going to Believe the Results
Last year, at the American Association for Diabetes (ADA) Scientific Sessions, a drug, called teplizumab, was able to significantly delay—for over two years—the onset of type 1 diabetes (T1D) in participants with a high risk of developing the disease. This was the first ever study in humans to show a delay in the onset of […]
ADA’s Scientific Sessions: Day 2
The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics, from beta cell replacement to regeneration and glucose and complications trials, all with the result to change things for the type 1 diabetes (T1D) community. Here are Drs. Eric Triplett, Randi Streisand, Hubert Tse and […]
